Patient care navigation and health copilot AI
Advoca
Advoca is a patient and carer app for cancer, rare disease, and complex-care journeys. Public materials describe appointment preparation, recording, summaries, trusted-source Q&A, and user-controlled sharing. Its privacy and consumer health disclosures are stronger than many peers, but public evidence still needs hands-on verification of summary correction, source traceability, and hallucination safeguards.
Public-source research has been drafted, often with AI assistance. No comprehensive human review is recorded unless the profile provenance says so.
Summary judgment · 84% toward patient-directed
Potentially agency-expanding
A patient-facing tool designed around appointment recall, preparation, and trusted sources may support agency, especially for complex diagnoses, but its claims and governance need independent review.
Patient agency
How this tool changes agency
Appointment planning, summaries, trusted-source Q&A, and journey organization directly support reflection and follow-through.
The policies disclose rights and AI fallibility, but app-level correction of summaries, transcripts, and Q&A outputs needs verification.
Patient-facing signals
Who does this AI serve?
The product is marketed to patients and carers and says it was built alongside cancer, rare disease, and complex-condition communities.
Can patients tell AI is involved?
Recording, AI summaries, and chatbot follow-up are visible features.
Can patients meaningfully choose?
Use appears voluntary and free, with public deletion, access, consent, and sharing controls described in policies.
Can patients correct or challenge what the AI produces?
The policies disclose rights and AI fallibility, but app-level correction of summaries, transcripts, and Q&A outputs needs verification.
Does it help patients understand or act?
Appointment planning, summaries, trusted-source Q&A, and journey organization directly support reflection and follow-through.
Text findings
Who is left out or burdened?
Evidence incomplete
The focus on cancer, rare disease, carers, and charities is promising, but language, disability, device, geography, and condition-coverage evidence remains limited.
What happens to patient data?
Meaningful public detail
Policies describe optional health data, account/technical data, cloud processors, temporary audio processing/deletion, stored transcripts/summaries/profile data, and optional separate-consent anonymized research use.
Are the clinical boundaries clear?
Clear in wording
Terms say Advoca is not a medical device, not FDA reviewed, not a HIPAA covered entity, not medical advice, and that AI can be inaccurate or hallucinate.
Who defined what good looks like?
Patient-community claims, limited evaluation
Public pages describe patient/carer/charity involvement, but independent outcome or safety evaluation was not found.
Review provenance
Criteria
Same HugoScore CAIHL-derived criteria for every tool; the public criteria are shown on How Reviews Work, displayed from site/data/criteria.json, with fuller method notes in SCORING_FRAMEWORK.md.
Reviewer
AI-assisted public-source draft; no named human reviewer is recorded in the profile data.
AI / model
Not recorded in profile data.
Human review
No comprehensive human review is recorded unless explicitly stated here.
Review date
Jun 8, 2026
Limitations
Deep public-source review of official website, privacy policy, consumer health data privacy policy, terms, and credible news context; no vendor interview, app walkthrough, or independent model evaluation.
Review method
Deep public-source review of official website, privacy policy, consumer health data privacy policy, terms, and credible news context; no vendor interview, app walkthrough, or independent model evaluation.
Draft profile · Medium draft